[Reliability of administrative databases in epidemiological research: the example of end-stage renal disease requiring renal replacement therapy in patients with diabetes]
- PMID: 19382087
[Reliability of administrative databases in epidemiological research: the example of end-stage renal disease requiring renal replacement therapy in patients with diabetes]
Abstract
Health and administrative databases are widely used in epidemiology, mostly in studies of chronic diseases, but biases may undermine the external validity of the results. In nephrology, the use of these data sources is in its early days and needs to be validated. The aim of this study was to compare the data on the incidence of ESRD and death in a cohort of patients with type 2 diabetes (DM2) obtained from administrative databases with the results of a traditional, well-performed cohort study. The study was conducted in the Health District of Venice (Italy) on a cohort of 18,416 DM2 patients on hypoglycemic drug therapy enrolled from 1 January 1998 to 31 December 2002 from administrative databases.Comorbid conditions were recorded from hospital discharge records, the database of death certificates was used to identify patients who died within 31 December 2004, and the database of the Dialysis and Transplantation Registry of the Veneto Region served to identify patients who started renal replacement therapy within 31 December 2004. Record linkage was performed using the unique personal identification codes (fiscal number) of Italian citizens. The cumulative incidence of ESRD was estimated using Gray's method for competing risks. The mortality rate was 50.95 per 1000 person-years, the ESRD incidence was 0.68 per 1000 person-years, with a relative risk of 2.62 with respect to all other causes of ESRD. The crude cumulative incidence of death was 22% and that of ESRD 0.33% at the end of follow-up. The results were similar to those obtained in traditional cohort studies. The results of our study prove the external validity of the administrative database approach in epidemiological studies in nephrology.
Similar articles
-
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.J Renin Angiotensin Aldosterone Syst. 2009 Dec;10(4):195-200. doi: 10.1177/1470320309352352. J Renin Angiotensin Aldosterone Syst. 2009. PMID: 20026868
-
The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.Rev Invest Clin. 2005 May-Jun;57(3):399-405. Rev Invest Clin. 2005. PMID: 16187699
-
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3. Am J Kidney Dis. 2012. PMID: 22051245
-
Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.Semin Nephrol. 1997 Jul;17(4):331-45. Semin Nephrol. 1997. PMID: 9241718 Review.
-
[Using Dialysis and Transplantation Registries for regional and small-area epidemiology].G Ital Nefrol. 2003 Mar-Apr;20(2):151-9. G Ital Nefrol. 2003. PMID: 12746800 Review. Italian.
Cited by
-
Prevalence of autosomal dominant polycystic kidney disease in the European Union.Nephrol Dial Transplant. 2017 Aug 1;32(8):1356-1363. doi: 10.1093/ndt/gfw240. Nephrol Dial Transplant. 2017. PMID: 27325254 Free PMC article.